Literature DB >> 18200819

Rheumatic heart disease: 15 years of clinical and immunological follow-up.

Roney O Sampaio1, Kellen C Fae, Lea M F Demarchi, Pablo M A Pomerantzeff, Vera D Aiello, Guilherme S Spina, Ana C Tanaka, Sandra E Oshiro, Max Grinberg, Jorge Kalil, Luiza Guilherme.   

Abstract

Rheumatic fever (RF) is a sequel of group A streptococcal throat infection and occurs in untreated susceptible children. Rheumatic heart disease (RHD), the major sequel of RF, occurs in 30%-45% of RF patients. RF is still considered endemic in some regions of Brazil and is responsible for approximately 90% of early childhood valvular surgery in the country. In this study, we present a 15-year clinical follow-up of 25 children who underwent surgical valvular repair. Histopathological and immunological features of heart tissue lesions of RHD patients were also evaluated. The patients presented severe forms of RHD with congestive symptoms at a very young age. Many of them had surgery at the acute phase of RF. Histological analysis showed the presence of dense valvular inflammatory infiltrates and Aschoff nodules in the myocardium of 21% of acute RHD patients. Infiltrating T-cells were mainly CD4+ in heart tissue biopsies of patients with rheumatic activity. In addition, CD4+ and CD8+ infiltrating T-cell clones recognized streptococcal M peptides and cardiac tissue proteins. These findings may open the possibilities of new ways of immunotherapy. In addition, we demonstrated that the surgical procedure during acute phase of the disease improved the quality of life of young RHD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18200819      PMCID: PMC2350126     

Source DB:  PubMed          Journal:  Vasc Health Risk Manag        ISSN: 1176-6344


  30 in total

1.  T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.

Authors:  L Guilherme; S E Oshiro; K C Faé; E Cunha-Neto; G Renesto; A C Goldberg; A C Tanaka; P M Pomerantzeff; M H Kiss; C Silva; F Guzman; M E Patarroyo; S Southwood; A Sette; J Kalil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 2.  Acute rheumatic fever.

Authors:  Jonathan R Carapetis; Malcolm McDonald; Nigel J Wilson
Journal:  Lancet       Date:  2005 Jul 9-15       Impact factor: 79.321

3.  Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin.

Authors:  J E Galvin; M E Hemric; K Ward; M W Cunningham
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 4.  T-cell vaccination for autoimmune disease: a panorama.

Authors:  I R Cohen
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

5.  Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium.

Authors:  S Roberts; S Kosanke; D Jankelow; C M Duran; M W Cunningham
Journal:  J Infect Dis       Date:  2000-12-20       Impact factor: 5.226

6.  Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis.

Authors:  Jeffrey E Galvin; Mark E Hemric; Stanley D Kosanke; Stephen M Factor; Anthony Quinn; Madeleine W Cunningham
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 7.  Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease.

Authors:  Madeleine W Cunningham
Journal:  Front Biosci       Date:  2003-05-01

Review 8.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

9.  Heart-directed autoimmunity: the case of rheumatic fever.

Authors:  L Guilherme; E Cunha-Neto; A C Tanaka; N Dulphy; A Toubert; J Kalil
Journal:  J Autoimmun       Date:  2001-05       Impact factor: 7.094

10.  Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever.

Authors:  Rajendranath Ramasawmy; Kellen C Faé; Guilherme Spina; Gabriel D Victora; Ana Cristina Tanaka; Selma A Palácios; Ana G Hounie; Euripides C Miguel; Sandra E Oshiro; Anna C Goldberg; Jorge Kalil; Luiza Guilherme
Journal:  Mol Immunol       Date:  2006-10-31       Impact factor: 4.407

View more
  5 in total

Review 1.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

Review 2.  Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases.

Authors:  Kamal M Kassem; Mahboob Ali; Nour-Eddine Rhaleb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-08-11       Impact factor: 2.457

3.  Incidental histological diagnosis of acute rheumatic myocarditis: case report and review of the literature.

Authors:  Guilherme S Spina; Roney O Sampaio; Carlos E Branco; George B Miranda; Vitor E E Rosa; Flávio Tarasoutchi
Journal:  Front Pediatr       Date:  2014-11-20       Impact factor: 3.418

4.  Predictors of the size of prosthetic aortic valve and in-hospital mortality in aortic valve replacement.

Authors:  Muhammad Shahzeb Khan; Faizan Imran Bawany; Mudassir Iqbal Dar; Muhammad Umer Ahmed; Mehwish Hussain; Mohammad Hussham Arshad; Asadullah Khan
Journal:  Glob J Health Sci       Date:  2014-04-16

5.  The effect of oral progesterone for the treatment of abnormal uterine bleeding in women taking warfarin following prosthetic valve replacement.

Authors:  Shafaq Nadeem; Shahid Abbas; Anjum Jalal
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.